Health tech giant Nvidia is collaborating with AstraZeneca and the University of Florida’s academic health center, UF Health, on new artificial intelligence research projects to accelerate drug discovery and improve patient care.
The organizations will use a new approach to training AI, called transformer neural networks, to allow researchers to leverage massive data sets, according to Kimberly Powell, vice president of Nvidia Healthcare, during a briefing with reporters. Transformer-based neural network architectures have become available only in the last several years.
Nvidia is collaborating with biopharmaceutical company AstraZeneca to build a model, trained using Nvidia DGX SuperPOD, an AI supercomputer, that will give researchers the ability to evaluate billions of molecules for potential drug candidates faster.